According to G1 Therapeutics
's latest financial reports the company has a price-to-book ratio of 6.56.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 4.47 | 11.78% |
2022-12-31 | 4.00 | 32.17% |
2021-12-31 | 3.02 | -21.63% |
2020-12-31 | 3.86 | -0.8% |
2019-12-31 | 3.89 | 95.73% |
2018-12-31 | 1.99 | -66.99% |
2017-12-31 | 6.02 | |
2016-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | 2.86 | -56.36% | ๐บ๐ธ USA |